KALA BIO
Development and commercialization of therapeutics using our proprietary nanoparticle-based Mucus Penetrating Particles.
Launch date
Employees
Market cap
CAD44.2m
Enterprise valuation
CAD20m (Public information from Sep 2024)
Share price
$5.8 KALA
Waltham Massachusetts (HQ)
Authorizing premium user...